RU CHEN to Proteomics
This is a "connection" page, showing publications RU CHEN has written about Proteomics.
Connection Strength
3.163
-
Metaproteomic analysis of human gut microbiome in digestive and metabolic diseases. Adv Clin Chem. 2020; 97:1-12.
Score: 0.523
-
Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol. 2016 Nov 14; 22(42):9288-9299.
Score: 0.417
-
Proteomics analysis of bodily fluids in pancreatic cancer. Proteomics. 2015 Aug; 15(15):2705-15.
Score: 0.375
-
Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. J Proteome Res. 2011 Jan 07; 10(1):200-9.
Score: 0.274
-
Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas. 2007 Jan; 34(1):70-9.
Score: 0.211
-
Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics. 2005 Apr; 4(4):523-33.
Score: 0.184
-
Proteome alterations in pancreatic ductal adenocarcinoma. Cancer Lett. 2020 01 28; 469:429-436.
Score: 0.128
-
Metaproteomics Study of the Gut Microbiome. Methods Mol Biol. 2019; 1871:123-132.
Score: 0.121
-
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Sci Rep. 2017 08 11; 7(1):7950.
Score: 0.110
-
Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. Proteomics Clin Appl. 2017 09; 11(9-10).
Score: 0.109
-
Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis. J Proteome Res. 2017 02 03; 16(2):665-676.
Score: 0.105
-
Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Lab Invest. 2015 Jan; 95(1):43-55.
Score: 0.091
-
Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges. Proteomics. 2013 Feb; 13(3-4):710-21.
Score: 0.080
-
Large-scale quantitative glycoproteomics analysis of site-specific glycosylation occupancy. Mol Biosyst. 2012 Nov; 8(11):2850-6.
Score: 0.078
-
Proteomics portrait of archival lesions of chronic pancreatitis. PLoS One. 2011; 6(11):e27574.
Score: 0.074
-
Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011 May 06; 10(5):2359-76.
Score: 0.071
-
Mass spectrometry based glycoproteomics--from a proteomics perspective. Mol Cell Proteomics. 2011 Jan; 10(1):R110.003251.
Score: 0.068
-
Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia. Mol Cancer. 2010 Jun 15; 9:149.
Score: 0.067
-
Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. J Proteome Res. 2014 Mar 07; 13(3):1293-306.
Score: 0.021
-
Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer. Proc Natl Acad Sci U S A. 2013 Nov 26; 110(48):19414-9.
Score: 0.021
-
Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J Proteome Res. 2012 Mar 02; 11(3):1937-48.
Score: 0.019
-
Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res. 2009 Feb; 8(2):787-97.
Score: 0.015